- Report
- July 2021
- 120 Pages
Global
From €3755EUR$4,100USD£3,197GBP
- Report
- October 2019
- 241 Pages
Global
From €4075EUR$4,450USD£3,470GBP
- Report
- November 2022
- 150 Pages
Global
From €4442EUR$4,850USD£3,782GBP
- Report
- May 2024
- 140 Pages
Global
From €4532EUR$4,949USD£3,859GBP
- Report
- July 2023
- 220 Pages
Global
€4391EUR$4,795USD£3,739GBP
- Report
- April 2024
- 80 Pages
Argentina
From €1374EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
Brazil
From €1374EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
China
From €1374EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
France
From €1374EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
Germany
From €1374EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
India
From €1374EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
Ireland
From €1374EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
Japan
From €1374EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
Poland
From €1374EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
Russia
From €1374EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
Saudi Arabia
From €1374EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
South Korea
From €1374EUR$1,500USD£1,170GBP
From €1374EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
United Kingdom
From €1374EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
Vietnam
From €1374EUR$1,500USD£1,170GBP

Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, such as cancer. Cancer markers are a type of biomarker that can be used to detect the presence of cancer in a patient. They can be used to diagnose, monitor, and predict the progression of cancer. Cancer markers can be proteins, hormones, enzymes, or other molecules that are produced by cancer cells or are associated with the presence of cancer.
Cancer markers are used in a variety of ways, including to detect the presence of cancer, to monitor the progression of the disease, and to predict the response to treatment. They can also be used to identify patients who are at risk for developing cancer.
The cancer marker market is a rapidly growing segment of the biomarker market. It is driven by the increasing prevalence of cancer, the development of new technologies for detecting and monitoring cancer, and the increasing demand for personalized medicine.
Companies in the cancer marker market include Abbott Laboratories, Agilent Technologies, Becton Dickinson, Bio-Rad Laboratories, Cepheid, and Roche Diagnostics. Show Less Read more